reference/11902483

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11902483

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	505
issn	0163-4356
issueIdentifier	5
pageRange	499-505
publicationName	Therapeutic Drug Monitoring
startingPage	499
bibliographicCitation	Kovarik JM, Tedesco H, Pascual J, Civati G, Bizot MN, Geissler J, Schmidli H. Everolimus therapeutic concentration range defined from a prospective trial with reduced-exposure cyclosporine in de novo kidney transplantation. Ther Drug Monit. 2004 Oct;26(5):499–505. doi: 10.1097/00007691-200410000-00007. PMID: 15385832.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fac7454e8b2f27572072cea612becff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46fd5522e18ef6f3a92464c32cce73ee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ecf3ec9a582c120b7d4c33fb52f0e60 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01dc27d6b4223dcf8bf826fd8fa9044a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_229008b2b96a1a1dbfce978032fc8869 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b331a46ad9050ae3ab88ceca23f8106f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f216f4f72e6712bedc5295276015e89b
date	200410
identifier	https://pubmed.ncbi.nlm.nih.gov/15385832 https://doi.org/10.1097/00007691-200410000-00007
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7634 https://portal.issn.org/resource/ISSN/0163-4356
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Everolimus Therapeutic Concentration Range Defined from a Prospective Trial with Reduced-Exposure Cyclosporine in De Novo Kidney Transplantation
discusses	http://id.nlm.nih.gov/mesh/M0029863 http://id.nlm.nih.gov/mesh/M0000480 http://id.nlm.nih.gov/mesh/M0025279 http://id.nlm.nih.gov/mesh/M000602394 http://id.nlm.nih.gov/mesh/M0011171
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D020123Q000493 http://id.nlm.nih.gov/mesh/D016030 http://id.nlm.nih.gov/mesh/D020123Q000031 http://id.nlm.nih.gov/mesh/D007166Q000493 http://id.nlm.nih.gov/mesh/D016572Q000493
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D019540 http://id.nlm.nih.gov/mesh/D020123Q000627 http://id.nlm.nih.gov/mesh/D020123Q000008 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D016903 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D016572Q000627 http://id.nlm.nih.gov/mesh/D007166Q000627 http://id.nlm.nih.gov/mesh/D016572Q000008 http://id.nlm.nih.gov/mesh/D007166Q000008 http://id.nlm.nih.gov/mesh/D000068338 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000305Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71463825 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497195 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121225388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24883466 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280754 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2909 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6435893 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25246316 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16404350 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71306795 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5458585 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123134263 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49867938

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248766214 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242749350

Total number of triples: 68.